Product
Danosumab
1 clinical trial
1 indication
Indication
Charcot ArthropathyClinical trial
RANKL Antibody (Danosumab) for Acute Charcot Neuro-osteoarthropathy Remission in Chronic Kidney DiseaseStatus: Completed, Estimated PCD: 2023-03-31
1 clinical trial
1 indication